医药生物行业今日涨2.08%，主力资金净流入38.45亿元

Market Overview - The Shanghai Composite Index rose by 1.22% on October 15, with 29 out of the 31 sectors experiencing gains, led by the power equipment and automotive sectors, which increased by 2.72% and 2.37% respectively [1] - The pharmaceutical and biological industry also saw an increase of 2.08% [1] - The steel and oil & petrochemical sectors were the only ones to decline, with decreases of 0.21% and 0.14% respectively [1] Capital Flow Analysis - The main capital flow showed a net outflow of 853 million yuan across the two markets, with 16 sectors experiencing net inflows [1] - The pharmaceutical and biological sector had the highest net inflow of 3.845 billion yuan, coinciding with its 2.08% increase [1] - The power equipment sector followed with a net inflow of 1.704 billion yuan [1] Pharmaceutical and Biological Sector Performance - Within the pharmaceutical and biological sector, 436 out of 475 stocks rose, with 5 hitting the daily limit up, while 33 stocks declined [2] - The top three stocks by net inflow were: - Sunflower (向日葵) with a net inflow of 438 million yuan and a price increase of 19.97% [2] - Guangsheng Tang (广生堂) with a net inflow of 278 million yuan and a price increase of 17.41% [2] - Hanyu Pharmaceutical (翰宇药业) with a net inflow of 172 million yuan and a price increase of 7.87% [2] Capital Outflow in Pharmaceutical Sector - The stocks with the highest net outflow in the pharmaceutical sector included: - Yifang Bio (益方生物-U) with a net outflow of 49.18 million yuan [4] - Yingke Medical (英科医疗) with a net outflow of 45.12 million yuan [4] - Dizhe Pharmaceutical (迪哲医药-U) with a net outflow of 39.01 million yuan [4]